Shopping Cart 0
Cart Subtotal
USD 0

Pacific Biosciences of California Inc (PACB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company's product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consumables. Its products enable the identification of novel genes; characterization of alternatively spliced isoforms in prominent gene families, and targeted sequencing, and provide real-time kinetic data for characterization of epigenomes. Pacific Biosciences' products are based on its novel single molecule, real-time (SMRT) sequencing technology. It caters to scientific and research communities, government and commercial entities. The company has subsidiaries in the US, Canada, Germany, Japan, China, Singapore, and the UK. Pacific Biosciences is headquartered in Menlo Park, California, the US.

Pacific Biosciences of California Inc (PACB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Pacific Biosciences of California Raises USD20.5 Million in Venture Funding 10

Equity Offering 11

Pacific Biosciences of California Raises USD69 Million in Public Offering of Shares 11

Pacific Biosciences Raises USD150 Million in Public Offering Of Common Stock 13

Acquisition 15

Illumina to Acquire Pacific Biosciences of California 15

Pacific Biosciences May Sell Itself 17

Pacific Biosciences of California Inc-Key Competitors 18

Pacific Biosciences of California Inc-Key Employees 19

Pacific Biosciences of California Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Financial Announcements 21

Aug 02, 2018: Pacific Biosciences of California reports second quarter 2018 financial results 21

Feb 01, 2018: Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results 22

Corporate Communications 23

Jul 31, 2018: Pacific Biosciences Appoints Christian Henry to Board of Directors 23

Legal and Regulatory 24

May 09, 2018: Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences 24

Feb 08, 2018: Oxford Nanopore Successfully Defends PacBio lawsuit 25

Government and Public Interest 26

Jul 30, 2018: Diversity of Unexpected CRISPR Edits Revealed by SMRT Sequencing 26

Other Significant Developments 27

Jun 06, 2018: Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria 27

May 21, 2018: Phase Genomics and Pacific Biosciences Announce the Release of Co-Developed Genome Assembly Phasing Software-'FALCON-Phase' 28

Mar 15, 2018: Study Demonstrates Potential for SMRT Sequencing to Improve the Safety of Gene Therapy Protocols 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8


List Of Table

List of Tables

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pacific Biosciences of California Raises USD20.5 Million in Venture Funding 10

Pacific Biosciences of California Raises USD69 Million in Public Offering of Shares 11

Pacific Biosciences Raises USD150 Million in Public Offering Of Common Stock 13

Illumina to Acquire Pacific Biosciences of California 15

Pacific Biosciences May Sell Itself 17

Pacific Biosciences of California Inc, Key Competitors 18

Pacific Biosciences of California Inc, Key Employees 19

Pacific Biosciences of California Inc, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Pacific Biosciences of California Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company's product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consumables. Its products enable the identification of novel genes; characterization of alternatively spliced isoforms in prominent gene families, and targeted sequencing, and provide real-time kinetic data for characterization of epigenomes. Pacific Biosciences' products are based on its novel single molecule, real-time (SMRT) sequencing technology. It caters to scientific and research communities, government and commercial entities. The company has subsidiaries in the US, Canada, Germany, Japan, China, Singapore, and the UK. Pacific Biosciences is headquartered in Menlo Park, California, the US.

Pacific Biosciences of California Inc (PACB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Pacific Biosciences of California Raises USD20.5 Million in Venture Funding 10

Equity Offering 11

Pacific Biosciences of California Raises USD69 Million in Public Offering of Shares 11

Pacific Biosciences Raises USD150 Million in Public Offering Of Common Stock 13

Acquisition 15

Illumina to Acquire Pacific Biosciences of California 15

Pacific Biosciences May Sell Itself 17

Pacific Biosciences of California Inc-Key Competitors 18

Pacific Biosciences of California Inc-Key Employees 19

Pacific Biosciences of California Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Financial Announcements 21

Aug 02, 2018: Pacific Biosciences of California reports second quarter 2018 financial results 21

Feb 01, 2018: Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results 22

Corporate Communications 23

Jul 31, 2018: Pacific Biosciences Appoints Christian Henry to Board of Directors 23

Legal and Regulatory 24

May 09, 2018: Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences 24

Feb 08, 2018: Oxford Nanopore Successfully Defends PacBio lawsuit 25

Government and Public Interest 26

Jul 30, 2018: Diversity of Unexpected CRISPR Edits Revealed by SMRT Sequencing 26

Other Significant Developments 27

Jun 06, 2018: Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria 27

May 21, 2018: Phase Genomics and Pacific Biosciences Announce the Release of Co-Developed Genome Assembly Phasing Software-'FALCON-Phase' 28

Mar 15, 2018: Study Demonstrates Potential for SMRT Sequencing to Improve the Safety of Gene Therapy Protocols 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8


List Of Table

List of Tables

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8

Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pacific Biosciences of California Raises USD20.5 Million in Venture Funding 10

Pacific Biosciences of California Raises USD69 Million in Public Offering of Shares 11

Pacific Biosciences Raises USD150 Million in Public Offering Of Common Stock 13

Illumina to Acquire Pacific Biosciences of California 15

Pacific Biosciences May Sell Itself 17

Pacific Biosciences of California Inc, Key Competitors 18

Pacific Biosciences of California Inc, Key Employees 19

Pacific Biosciences of California Inc, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Pacific Biosciences of California Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.